Dr. Charles Leslie Whitaker, PHARMICIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 116 Kentucky Ave, Caraway, AR 72419 Phone: 870-482-3332 Fax: 870-482-3525 |
News Archive
Children who are exposed to general anesthesia from birth to age 2 have developmental testing results in kindergarten that are similar to those of children who have not been exposed, according to a new study published in the October issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists.
Celsion Corporation, a leading oncology drug development company, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for Orphan Drug Designation for ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Newly published results from a clinical study of the Diabetes Insulin Guidance System (DIGS-), under development by Hygieia, Inc., demonstrate DIGS' potential to improve blood glucose control for insulin-using patients with type 2 or type 1 diabetes. DIGS automatically adjusted insulin dosage based on each individual's reported blood glucose results.
› Verified 5 days ago